Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Hemodynamic Markers in the Anterior Circulation as Predictors of Recurrent Stroke in Patients With Intracranial Stenosis.

Wabnitz AM, Derdeyn CP, Fiorella DJ, Lynn MJ, Cotsonis GA, Liebeskind DS, Waters MF, Lutsep H, López-Cancio E, Turan TN, Montgomery J, Janis LS, Lane B, Chimowitz MI; SAMMPRIS Investigators.

Stroke. 2018 Dec 11:STROKEAHA118020840. doi: 10.1161/STROKEAHA.118.020840. [Epub ahead of print]

PMID:
30580705
2.

Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow.

Tian DC, Shi K, Zhu Z, Yao J, Yang X, Su L, Zhang S, Zhang M, Gonzales RJ, Liu Q, Huang D, Waters MF, Sheth KN, Ducruet AF, Fu Y, Lou M, Shi FD.

Ann Neurol. 2018 Nov;84(5):717-728. doi: 10.1002/ana.25352. Epub 2018 Nov 2.

3.

C-terminal proline deletions in KCNC3 cause delayed channel inactivation and an adult-onset progressive SCA13 with spasticity.

Khare S, Galeano K, Zhang Y, Nick JA, Nick HS, Subramony SH, Sampson J, Kaczmarek LK, Waters MF.

Cerebellum. 2018 Oct;17(5):692-697. doi: 10.1007/s12311-018-0950-5.

PMID:
29949095
4.

Protective effects of the angiotensin II AT2 receptor agonist compound 21 in ischemic stroke: a nose-to-brain delivery approach.

Bennion DM, Jones CH, Dang AN, Isenberg J, Graham JT, Lindblad L, Domenig O, Waters MF, Poglitsch M, Sumners C, Steckelings UM.

Clin Sci (Lond). 2018 Mar 15;132(5):581-593. doi: 10.1042/CS20180100. Print 2018 Mar 15.

PMID:
29500223
5.

Stroke Hospital Characteristics in the Florida-Puerto Rico Collaboration to Reduce Stroke Disparities Study.

Ciliberti-Vargas MA, Gardener H, Wang K, Dong C, Yi L, Romano JG, Robichaux M, Waddy SP, Nobo U, Diaz-Acosta S, Rundek T, Waters MF, Sacco RL.

South Med J. 2017 Jul;110(7):466-474. doi: 10.14423/SMJ.0000000000000667.

6.

A KCNC3 mutation causes a neurodevelopmental, non-progressive SCA13 subtype associated with dominant negative effects and aberrant EGFR trafficking.

Khare S, Nick JA, Zhang Y, Galeano K, Butler B, Khoshbouei H, Rayaprolu S, Hathorn T, Ranum LPW, Smithson L, Golde TE, Paucar M, Morse R, Raff M, Simon J, Nordenskjöld M, Wirdefeldt K, Rincon-Limas DE, Lewis J, Kaczmarek LK, Fernandez-Funez P, Nick HS, Waters MF.

PLoS One. 2017 May 3;12(5):e0173565. doi: 10.1371/journal.pone.0173565. eCollection 2017.

7.

Dapagliflozin improves insulin resistance and glucose intolerance in a novel transgenic rat model of chronic glucose overproduction and glucose toxicity.

Joannides CN, Mangiafico SP, Waters MF, Lamont BJ, Andrikopoulos S.

Diabetes Obes Metab. 2017 Aug;19(8):1135-1146. doi: 10.1111/dom.12923. Epub 2017 Apr 6.

PMID:
28244693
8.

Racial-Ethnic Disparities in Acute Stroke Care in the Florida-Puerto Rico Collaboration to Reduce Stroke Disparities Study.

Sacco RL, Gardener H, Wang K, Dong C, Ciliberti-Vargas MA, Gutierrez CM, Asdaghi N, Burgin WS, Carrasquillo O, Garcia-Rivera EJ, Nobo U, Oluwole S, Rose DZ, Waters MF, Zevallos JC, Robichaux M, Waddy SP, Romano JG, Rundek T; FL‐PR CReSD Investigators and Collaborators.

J Am Heart Assoc. 2017 Feb 14;6(2). pii: e004073. doi: 10.1161/JAHA.116.004073.

9.

Serum activity of angiotensin converting enzyme 2 is decreased in patients with acute ischemic stroke.

Bennion DM, Rosado CA, Haltigan EA, Regenhardt RW, Sumners C, Waters MF.

J Renin Angiotensin Aldosterone Syst. 2016 Aug 3;17(3). pii: 1470320316661060. doi: 10.1177/1470320316661060. Print 2016 Jul.

10.

Kv3.3 Channels Bind Hax-1 and Arp2/3 to Assemble a Stable Local Actin Network that Regulates Channel Gating.

Zhang Y, Zhang XF, Fleming MR, Amiri A, El-Hassar L, Surguchev AA, Hyland C, Jenkins DP, Desai R, Brown MR, Gazula VR, Waters MF, Large CH, Horvath TL, Navaratnam D, Vaccarino FM, Forscher P, Kaczmarek LK.

Cell. 2016 Apr 7;165(2):434-448. doi: 10.1016/j.cell.2016.02.009. Epub 2016 Mar 17.

11.

Rare neurological channelopathies--networks to study patients, pathogenesis and treatment.

Jen JC, Ashizawa T, Griggs RC, Waters MF.

Nat Rev Neurol. 2016 Apr;12(4):195-203. doi: 10.1038/nrneurol.2016.18. Epub 2016 Mar 4. Review.

12.

Thoracoscopic Ablation With Appendage Ligation Versus Medical Therapy for Stroke Prevention: A Proof-of-Concept Randomized Trial.

Beaver TM, Hedna VS, Khanna AY, Miles WM, Price CC, Schmalfuss IM, Aalaei-Andabili SH, Waters MF.

Innovations (Phila). 2016 Mar-Apr;11(2):99-105. doi: 10.1097/IMI.0000000000000226.

13.
14.

Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial.

Waters MF, Hoh BL, Lynn MJ, Kwon HM, Turan TN, Derdeyn CP, Fiorella D, Khanna A, Sheehan TO, Lane BF, Janis S, Montgomery J, Chimowitz MI; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial Investigators.

JAMA Neurol. 2016 Mar;73(3):308-15. doi: 10.1001/jamaneurol.2015.4315. Erratum in: JAMA Neurol. 2016 Apr;73(4):481.

15.

CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease.

Hoh BL, Gong Y, McDonough CW, Waters MF, Royster AJ, Sheehan TO, Burkley B, Langaee TY, Mocco J, Zuckerman SL, Mummareddy N, Stephens ML 2nd, Ingram C, Shaffer CM, Denny JC, Brilliant MH, Kitchner TE, Linneman JG, Roden DM, Johnson JA.

J Neurosurg. 2016 Jun;124(6):1746-51. doi: 10.3171/2015.6.JNS15795. Epub 2015 Nov 20.

16.

Haptoglobin phenotype predicts the development of focal and global cerebral vasospasm and may influence outcomes after aneurysmal subarachnoid hemorrhage.

Leclerc JL, Blackburn S, Neal D, Mendez NV, Wharton JA, Waters MF, Doré S.

Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1155-60. doi: 10.1073/pnas.1412833112. Epub 2015 Jan 12.

17.

A Non-Surgeon's Guide to Surgical Management of Atrial Fibrillation.

Cai PY, Derequito R, Mishra M, Tenkabail S, Bodhit A, Ansari S, Ganji S, Saravanapavan P, Shekhar CC, Abukhalil F, Waters MF, Beaver TM, Hedna VS.

J Surg (Northborough). 2013 Oct 14;1(2). pii: 1000010.

18.

Endothelin-1-mediated vasoconstriction alters cerebral gene expression in iron homeostasis and eicosanoid metabolism.

Bickford JS, Ali NF, Nick JA, Al-Yahia M, Beachy DE, Doré S, Nick HS, Waters MF.

Brain Res. 2014 Nov 7;1588:25-36. doi: 10.1016/j.brainres.2014.09.022. Epub 2014 Sep 16.

PMID:
25230250
19.

KCNC3(R420H), a K(+) channel mutation causative in spinocerebellar ataxia 13 displays aberrant intracellular trafficking.

Gallego-Iradi C, Bickford JS, Khare S, Hall A, Nick JA, Salmasinia D, Wawrowsky K, Bannykh S, Huynh DP, Rincon-Limas DE, Pulst SM, Nick HS, Fernandez-Funez P, Waters MF.

Neurobiol Dis. 2014 Nov;71:270-9. doi: 10.1016/j.nbd.2014.08.020. Epub 2014 Aug 22.

20.

Vagus nerve stimulation in ischemic stroke: old wine in a new bottle.

Cai PY, Bodhit A, Derequito R, Ansari S, Abukhalil F, Thenkabail S, Ganji S, Saravanapavan P, Shekar CC, Bidari S, Waters MF, Hedna VS.

Front Neurol. 2014 Jun 24;5:107. doi: 10.3389/fneur.2014.00107. eCollection 2014. Review.

21.

Role of inflammatory markers in Takayasu arteritis disease monitoring.

O'Connor TE, Carpenter HE, Bidari S, Waters MF, Hedna VS.

BMC Neurol. 2014 Mar 28;14:62. doi: 10.1186/1471-2377-14-62.

22.

Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.

Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators.

Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26.

23.

Spontaneous swallowing frequency has potential to identify dysphagia in acute stroke.

Crary MA, Carnaby GD, Sia I, Khanna A, Waters MF.

Stroke. 2013 Dec;44(12):3452-7. doi: 10.1161/STROKEAHA.113.003048. Epub 2013 Oct 22.

24.

Mutation in the kv3.3 voltage-gated potassium channel causing spinocerebellar ataxia 13 disrupts sound-localization mechanisms.

Middlebrooks JC, Nick HS, Subramony SH, Advincula J, Rosales RL, Lee LV, Ashizawa T, Waters MF.

PLoS One. 2013 Oct 7;8(10):e76749. doi: 10.1371/journal.pone.0076749. eCollection 2013.

25.

Atrial Fibrillation - A Common Ground for Neurology and Cardiology.

Abukhalil F, Bodhit A, Cai PY, Ansari S, Thenkabail S, Ganji S, Saravanapavan P, Chandra Shekhar C, Waters MF, Beaver TM, Shushrutha Hedna V.

J Atr Fibrillation. 2013 Aug 31;6(2):550. doi: 10.4022/jafib.550. eCollection 2013 Aug-Sep. Review.

26.

Intracranial hypotension masquerading as nonconvulsive status epilepticus: report of 3 cases.

Hedna VS, Kumar A, Miller B, Bidari S, Salardini A, Waters MF, Hella M, Valenstein E, Eisenschenk S.

J Neurosurg. 2014 Mar;120(3):624-7. doi: 10.3171/2013.7.JNS112308. Epub 2013 Aug 23.

PMID:
23971956
27.

Prospective quality initiative to maximize dysphagia screening reduces hospital-acquired pneumonia prevalence in patients with stroke.

Titsworth WL, Abram J, Fullerton A, Hester J, Guin P, Waters MF, Mocco J.

Stroke. 2013 Nov;44(11):3154-60. doi: 10.1161/STROKEAHA.111.000204. Epub 2013 Aug 20.

PMID:
23963330
28.

Comprehensive phenotype of the p.Arg420his allelic form of spinocerebellar ataxia type 13.

Subramony SH, Advincula J, Perlman S, Rosales RL, Lee LV, Ashizawa T, Waters MF.

Cerebellum. 2013 Dec;12(6):932-6. doi: 10.1007/s12311-013-0507-6.

29.

Hemispheric differences in ischemic stroke: is left-hemisphere stroke more common?

Hedna VS, Bodhit AN, Ansari S, Falchook AD, Stead L, Heilman KM, Waters MF.

J Clin Neurol. 2013 Apr;9(2):97-102. doi: 10.3988/jcn.2013.9.2.97. Epub 2013 Apr 4.

30.

Vessel wall enhancement in herpes simplex virus central nervous system vasculitis.

Guerrero WR, Dababneh H, Hedna S, Johnson JA, Peters K, Waters MF.

J Clin Neurosci. 2013 Sep;20(9):1318-9. doi: 10.1016/j.jocn.2012.10.024. Epub 2013 Mar 18.

PMID:
23517674
31.

Endothelin-1 induced middle cerebral artery occlusion model for ischemic stroke with laser Doppler flowmetry guidance in rat.

Ansari S, Azari H, Caldwell KJ, Regenhardt RW, Hedna VS, Waters MF, Hoh BL, Mecca AP.

J Vis Exp. 2013 Feb 16;(72). pii: 50014. doi: 10.3791/50014.

32.

Trends in the management of atrial fibrillation: A neurologist's perspective.

Hedna VS, Favilla CG, Guerrero WR, Patel A, Gottipati A, Bidari S, Beaver T, Waters MF.

J Cardiovasc Dis Res. 2012 Oct;3(4):255-64. doi: 10.4103/0975-3583.102690.

33.

Takayasu's arteritis: Is it a reversible disease? Case Report and Literature Review.

Hedna VS, Patel A, Bidari S, Elder M, Hoh BL, Yachnis A, Waters MF.

Surg Neurol Int. 2012;3:132. doi: 10.4103/2152-7806.102947. Epub 2012 Oct 27.

34.

Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS).

Fiorella D, Derdeyn CP, Lynn MJ, Barnwell SL, Hoh BL, Levy EI, Harrigan MR, Klucznik RP, McDougall CG, Pride GL Jr, Zaidat OO, Lutsep HL, Waters MF, Hourihane JM, Alexandrov AV, Chiu D, Clark JM, Johnson MD, Torbey MT, Rumboldt Z, Cloft HJ, Turan TN, Lane BF, Janis LS, Chimowitz MI; SAMMPRIS Trial Investigators.

Stroke. 2012 Oct;43(10):2682-8. Epub 2012 Sep 13.

35.

Oculomotor and visual axis systems sparing in spinocerebellar ataxia type 13(R420H).

Waters MF, Subramony SH, Advincula J, Perlman S, Ashizawa T.

Neurology. 2012 Sep 11;79(11):1181-2. doi: 10.1212/WNL.0b013e3182698d5c. Epub 2012 Aug 29. No abstract available.

36.

Seizure Mimicking Stroke: Role of CT Perfusion.

Hedna VS, Shukla PP, Waters MF.

J Clin Imaging Sci. 2012;2:32. doi: 10.4103/2156-7514.97728. Epub 2012 Jun 29.

37.

Race and income disparity in ischemic stroke care: nationwide inpatient sample database, 2002 to 2008.

Kimball MM, Neal D, Waters MF, Hoh BL.

J Stroke Cerebrovasc Dis. 2014 Jan;23(1):17-24. doi: 10.1016/j.jstrokecerebrovasdis.2012.06.004. Epub 2012 Jul 17.

PMID:
22818388
38.

Posterior reversible encephalopathy syndrome (PRES) and CT perfusion changes.

Hedna VS, Stead LG, Bidari S, Patel A, Gottipati A, Favilla CG, Salardini A, Khaku A, Mora D, Pandey A, Patel H, Waters MF.

Int J Emerg Med. 2012 Feb 29;5:12. doi: 10.1186/1865-1380-5-12.

39.

Endovascular intervention for acute stroke due to infective endocarditis: case report.

Dababneh H, Hedna VS, Ford J, Taimeh Z, Peters K, Mocco J, Waters MF.

Neurosurg Focus. 2012 Feb;32(2):E1. doi: 10.3171/2011.11.FOCUS11263.

PMID:
22296678
40.

Intracranial stents for treatment of acute ischemic stroke: evolution and current status.

Ansari S, McConnell DJ, Velat GJ, Waters MF, Levy EI, Hoh BL, Mocco J.

World Neurosurg. 2011 Dec;76(6 Suppl):S24-34. doi: 10.1016/j.wneu.2011.02.031. Review.

PMID:
22182268
41.

Direct thrombectomy using the Penumbra thromboaspiration catheter for the treatment of cerebral venous sinus thrombosis.

Velat GJ, Skowlund CJ, Waters MF, Mocco J, Hoh BL.

World Neurosurg. 2012 Mar-Apr;77(3-4):591.e15-8. doi: 10.1016/j.wneu.2011.02.020. Epub 2011 Nov 7.

PMID:
22120408
42.

Impact of intracranial self-expanding stents in the treatment of acute ischemic stroke: efficacy and limitations.

Ansari S, McConnell DJ, Azari H, Levy EI, Hoh BL, Waters MF, Mocco J.

J Neurointerv Surg. 2011 Dec 1;3(4):364-8. doi: 10.1136/jnis.2011.004614. Epub 2011 Feb 10. Review.

PMID:
21990463
43.

Computed tomographic perfusion imaging of non-hemorrhagic cerebral hyperperfusion syndrome and reversal following medical treatment after carotid artery angioplasty and stenting.

Vasquez RA, Waters MF, Skowlund CJ, Mocco J, Hoh BL.

J Neurointerv Surg. 2012 May;4(3):e2. doi: 10.1136/jnis.2010.003558. Epub 2011 Jun 16.

PMID:
21990434
44.

Stenting versus aggressive medical therapy for intracranial arterial stenosis.

Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Torbey MT, Zaidat OO, Rumboldt Z, Cloft HJ; SAMMPRIS Trial Investigators.

N Engl J Med. 2011 Sep 15;365(11):993-1003. doi: 10.1056/NEJMoa1105335. Epub 2011 Sep 7. Erratum in: N Engl J Med. 2012 Jul 5;367(1):93.

45.

Aggressive intervention to treat a young woman with intracranial hemorrhage following unsuccessful intravenous thrombolysis for left middle cerebral artery occlusion. Case report.

Fargen KM, Hoh BL, Fautheree GL, Morgan WR, Velat GJ, Waters MF, Mocco J.

J Neurosurg. 2011 Aug;115(2):359-63. doi: 10.3171/2011.3.JNS101514. Epub 2011 Apr 15.

PMID:
21495825
46.

Frequency of KCNC3 DNA variants as causes of spinocerebellar ataxia 13 (SCA13).

Figueroa KP, Waters MF, Garibyan V, Bird TD, Gomez CM, Ranum LP, Minassian NA, Papazian DM, Pulst SM.

PLoS One. 2011 Mar 29;6(3):e17811. doi: 10.1371/journal.pone.0017811.

47.

Recanalization therapy for acute ischemic stroke, part 1: surgical embolectomy and chemical thrombolysis.

Ansari S, Rahman M, Waters MF, Hoh BL, Mocco J.

Neurosurg Rev. 2011 Jan;34(1):1-9. doi: 10.1007/s10143-010-0293-2. Epub 2010 Nov 24. Review.

PMID:
21107631
48.

Recanalization therapy for acute ischemic stroke, part 2: mechanical intra-arterial technologies.

Ansari S, Rahman M, McConnell DJ, Waters MF, Hoh BL, Mocco J.

Neurosurg Rev. 2011 Jan;34(1):11-20. doi: 10.1007/s10143-010-0294-1. Epub 2010 Nov 24. Review.

PMID:
21107630
49.
50.

Acute intraprocedural thrombus formation during wingspan intracranial stent placement for intracranial atherosclerotic disease.

Lawson MF, Fautheree GL, Waters MF, Decker DA, Mocco JD, Hoh BL.

Neurosurgery. 2010 Sep;67(3 Suppl Operative):ons166-70; discussion ons170. doi: 10.1227/01.NEU.0000380948.85926.3C.

PMID:
20679932

Supplemental Content

Loading ...
Support Center